Halásková , M. – Halásková , R. ( 2017 ): PublicExpenditures in Areas of Public Sector: Analysis and Evaluation in EU Countries . Scientific Papers of the University of Pardubice – Series D 40 ( 2 ): 49 – 60
publicexpenditure, some of which may foster economic growth. The discussion on the impact of the tax structure on growth is mainly focused on the relative merits of direct vs indirect taxes, and especially on their ability to create a more growth
from the time period between 2006 and 2015. At the input side, we analyze mainly the publicexpenditure into selected sectors. At the output side, we focus on the number of research publications, number of patents filed by the public sector and the
Arrow , K. J.
( 1969 ): The Organisation of Economic Activity: Issues Pertinent to the Choice of Market Versus Non Market Allocation . In: The Analysis and Evaluation of PublicExpenditure: The PPB System . Vol. I. US Joint Committee
Authors:GheorghiŢa Dincă, Marius Sorin Dincă, and Maria LetiŢia Andronic
1 Introduction This study aimed to identify the most efficient healthcare systems using a sample of 17 EU states. The health sector is an area where publicexpenditures are of a great importance so that the findings of this study would have strong
Authors:Norbert Novák, Péter Miklós Kőmíves, Mónika Harangi-Rákos, and Károly Pető
more attractive for investors publicexpenditures needed to be completed in order to satisfy – for example – the infrastructural needs of the investors. In this case the publicexpenditures could be covered by local fiscal resources mostly based on the
, Bangladesh, Australia and the United States.
In 2007–08, publicexpenditure on education as % of GDP was 3.81 % and as a percentage of Government budget was 16.80 %. The publicexpenditure on higher education as a percentage of GDP was 0.4 % in 2007
– In 2006, total drug-related publicexpenditure (2) represented 0.05% of GDP, with 63.3% for public order and safety, 14.8% for treatment, 7.6% for prevention, 1.8% for coordination, 1.3% for education, 0.9% for harm reduction, and 10.3% for other